Navigation Links
A Recent Study by ITG's Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
Date:6/1/2011

ation process.  Neurologists described an overwhelming degree of red tape affiliated with the reimbursement of Ampyra.  Of surveyed Ampyra prescribers, 40% reported reimbursement issues with the drug.  Unlike Gilenya, Ampyra's launch appears to be greatly hindered by these issues.  Since neurologists view Ampyra's efficacy as questionable and limited to a niche subset of the MS population, they seem less willing to jump through hoops to get patients on it.  The difference in how neurologists are handling Gilenya versus Ampyra is indicative of the cost-benefit analysis that is inherent in every treatment decision.  Neurologists have made more of a commitment to Gilenya because they believe it can deliver meaningful benefits to their patients and Novartis is facilitating the delivery of those benefits.  This hasn't been the case with Ampyra.  Data from ITG's proprietary physician panel have pointed to waning demand for Ampyra, which the study concludes is unlikely to improve without material changes to the drug's reimbursement situation.

Conducted in April - May 2011, the study includes analysis of a targeted Internet survey of 100 neurologists and proprietary longitudinal treatment data from a panel of 225 neurologists spanning 2005-2011. Through triangulation of quantitative and qualitative findings from these two data sources, the report provides an in-depth look at the launch of Gilenya and the potential for future oral disease-modifying drugs in the multiple sclerosis market. In addition, the report evaluates uptake and use of Acorda Therapeutics' Ampyra as a supportive agent in the MS space.

About Event Pulse


SOURCE ITG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
4. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
5. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
6. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
9. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
10. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
11. Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015  Encision Inc. (PK:ECIA), a medical device ... electrosurgical burns in minimally invasive surgery, today announced financial ... June 30, 2015. The Company posted quarterly ... loss of $213 thousand, or $(0.02) per share. These ... a net loss of $202 thousand, or $(0.02) per ...
(Date:8/2/2015)... -- Mandatory takeover offer for the ... the "Company") is pleased to announce the signing of ... Marijan Han žeković to acquire his 63.3% holding (equivalent ... Croatian listed pharmaceutical business.   Dechra is ... €51.4 million for the entire share capital on a ...
(Date:7/31/2015)... More than 1,500 substance abuse prevention and treatment specialists ... Indianapolis Aug. 2-6 for Community Anti-Drug Coalitions ... The week-long training, held at the JW Marriott, will ... biggest public health challenges – youth drug use. ... intensive training opportunity, offering more than 70 half-day and ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 2Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 3Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 4Dechra to Acquire 63.3% Shareholding (£19.4m) in Genera d.d. Croatia 5Community Leaders From Across The Country Head To Indianapolis For CADCA 2015 Mid-Year Training Institute Aug. 2-6 2
... NVAX ), a clinical-stage vaccine company, announced today ... presenting at the ROTH 23rd Annual OC Growth Stock Conference ... The Ritz Carlton, Laguna Niguel, CA.  A live audio-only webcast ... website at www.novavax.com under Investors/Events, and a replay ...
... and LONDON, March 11, 2011 Tolerx, ... 3 DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 ... of change in C-peptide at month 12 in patients ... Following preliminary review of the data, no new or ...
Cached Medicine Technology:Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 2Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 3Tolerx and GlaxoSmithKline Announce Phase 3 Defend-1 Study of Otelixizumab in Type 1 Diabetes Did Not Meet Its Primary Endpoint 4
(Date:8/3/2015)... ... August 03, 2015 , ... ... solutions for drugs, biologics and consumer health products, today welcomed the announcement by ... OPKO’s New Drug Application for a new treatment for chronic kidney disease (CKD) ...
(Date:8/3/2015)... CA (PRWEB) , ... August 03, 2015 , ... ... suffering from ALS and amputation , AUGUST 3, 2015 – Since winning a ... in March 2015, Not Impossible – an organization whose mission is to develop ...
(Date:8/3/2015)... ... August 03, 2015 , ... Results of a ... for Healthcare Research and Policy Analysis show widespread support for the U.S. Affordable ... agreed or strongly agreed that the controversial law passed in 2010 had “more ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its least visited ... untapped ground water aquifers, whose main outflow is at Ahjumawi Lava Springs, part ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... A July ... Injection of Stem Cells Found to Release Natural Painkiller That Can Last 'For Five ... patients. According to the report, the new study showed that harvesting stem cell-rich bone ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... Jan. 12 David M. Klein, Ph.D., original co-owner ... Arizona and a developer of that national brand, has ... centers to Arizona.Natural Weight(TM) For Optimized Living is a ... that enables you to become healthier at any weight, ...
... FRANCISCO, Jan. 12 Within health care, dermatology,professionals play ... , The Dermatology Nurses, Association ... practice in a variety,of learning formats and the opportunity ... annual conference slated for March,4-7 at the Hilton San ...
... Also Appoints Industry Veteran Steve Shulman to BoardHOUSTON, ... first and largest provider of outsourced medical implantable ... announced today that its board of directors has ... The company announced the appointment following its second ...
... providing high-quality speech pathology services, according to University ... , Completed through UQ,s School of Health and ... language disorders could be validly and reliably assessed ... , "Having worked clinically with people living with ...
... 12 A partnership between Command Spanish(R), Inc. and ... providers of nursing education, makes the two companies co-providers ... instruction being provided by the two companies allows nurses ... occupational Spanish. Two new courses are available online to ...
... Inc. (Nasdaq: ALXN ), today announced that ... fourth quarter and full year ended December 31, 2008 ... open. Following the release of the financials, Alexion management ... on Thursday, February 12, 2009, at 10:00 a.m. Eastern ...
Cached Medicine News:Health News:Dr. David M. Klein, Innovator of Smart for Life in Arizona, Brings New Weight Management and Wellness Concept to Arizona 2Health News:Dr. David M. Klein, Innovator of Smart for Life in Arizona, Brings New Weight Management and Wellness Concept to Arizona 3Health News:Hop the Trolley for DNA's 27th Annual Conference 2Health News:Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board 2Health News:Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board 3Health News:UQ research finds speech disorders can be assessed from a distance 2Health News:Nurses: Command Spanish Online's Occupational Spanish Language Course Accepted for Credit by the American Nurses Credentialing Center (ANCC) 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: